MEDNAX to Present at Raymond James 32nd Annual Institutional Investors Conference
FORT LAUDERDALE, Fla., Mar 01, 2011 (BUSINESS WIRE) -- MEDNAX, Inc., (NYSE:MD) today announced that it is scheduled to make a presentation on Monday, March 7, 2011, at 8:05 a.m., Eastern Time, to investors attending the Raymond James 32nd Annual Institutional Investors Conference in Orlando, FL.
The presentation by MEDNAX's Chief Financial Officer, Vivian Lopez-Blanco, will be broadcast through a live audio Webcast and will be available for replay at
ABOUT MEDNAX
MEDNAX, Inc., is a national medical group that comprises the nation's leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 300 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric critical care physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. In 2007, the Company expanded into anesthesia services. Today, American Anesthesiology includes more than 700 anesthesiologists and advanced practitioners. MEDNAX, through its affiliated professional corporations, employs more than 1,650 physicians in 33 states and Puerto Rico. Additional information is available at www.mednax.com.
SOURCE: MEDNAX, Inc.
MEDNAX, Inc.
Bob Kneeley, 954-384-0175, Ext. 5300
Vice President, Investor Relations
bob_kneeley@mednax.com